Braunschweig Municipal Hospital has installed a groundbreaking process for molecular tumor analysis using next-generation sequencing (NGS). We spoke to the hospital’s medical director, Thomas Bartkiewicz, MD, and the head of the Department of Pathology, Ansgar Dellmann, MD, about the role that tumor analysis plays in oncology at the hospital and about the collaboration with Siemens Healthineers subsidiary NEO New Oncology, which executed the project.